Cabaletta Bio, Inc (CABA) - Operatsion marja

Cabaletta Bio Inc. (CABA) kompaniyasining korporativ logotipi

Cabaletta Bio, Inc. (CABA) hozirda hech qanday savdo daromadiga ega bo'lmagan klinik bosqichdagi ishlab chiquvchi bo'lib, bu uning moliyaviy holati eksklyuziv ravishda tadqiqot va ishlanmalar (R&D) xarajatlariga asoslanganligini anglatadi. GURU.Markets operatsion marja egri chizig'i 0.00 qiymatida mustahkamlangan metrika bilan ta'minlangan bo'lib, bu sinov natijalari va texnologik kengayish imkoniyatlariga bog'liqlikni aks ettiradi. CABA-iREGT uchun patentlar va terapiya uchun FDA ning qat'iy xavfsizlik nazoratlari bozorga kirish uchun yuqori to'siqlarni ta'minlaydi.

cabalettabio.com (CABA): Operatsion rentabellik 04.07.2022dan 19.11.2026gacha

Cabaletta Bio (CABA) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:Cabaletta Bio Inc., CABA
cabalettabio.com brendining mahsuloti

Ushbu ko'rsatkich xarajatlarni boshqarish samaradorligini baholash uchun asosiy filtr vazifasini o'taydi va foizlar hamda soliqlar to'lanishidan oldingi daromadlarda operatsion foydaning ulushini o'lchaydi. Operatsion marjani tahlil qilish biznesning o'z asosiy jarayonlaridan pul oqimini yaratish qobiliyatini aniqlash imkonini beradi. Cabaletta Bio, Inc. (CABA) uchun ushbu parametr uning R&D markazini saqlash xarajatlarini aks ettiradi, chunki elita bioinformatiklarini saqlab qolish uchun sarflanadigan yuqori xarajatlar ushbu metrika dinamikasiga bevosita ta'sir qiladi.

Asosiy raqobatchilar

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|PGEN (Precigen) - Operatsion foyda bo'yicha sotuv rentabelligi|pharming.com (PHAR) - Operatsion rentabellik|Nektar Corp (NKTR) - Operatsion marja|UPB (upstreambio.com) - Operatsion marja|ZBIO: Operatsion foyda normasi|Operatsion marja IMNM|Operatsion faoliyat rentabelligi Gossamer Bio Inc|Operatsion marja KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operatsion foyda marjasi|PVLA: Sotuvning operatsion marjasi|Operatsion foyda marjasi SVRA|RIGL: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ANAB|ATXS (Astria Corp) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ENGN (enGene Bio)|Operatsion marja RAPT|Operatsion faoliyat rentabelligi Aerovate Therapeutics|Operatsion rentabellik Aclaris Therapeutics Inc. ACRS|Operatsion faoliyat rentabelligi Kyverna Therapeutics Inc. (KYTX)|TLSA - Operatsion rentabellik|Sotuvning operatsion rentabelligi Ventyx Biosciences|THTX (theratech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operatsion marja|Sotuvning operatsion rentabelligi Agenus Inc. AGEN|Sotuvning operatsion marjasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operatsion foyda normasi|Operatsion rentabellik atyrpharma.com ATYR|Operatsion marja Adagene Corp ADAG|IMA - Operatsion rentabellik|Operatsion foyda normasi STTK (Shattuck Labs)|EQ: Operatsion marja|Connect Biopharma (CNTB) - Operatsion marja|Operatsion rentabellik Immunic|Operatsion marja atarabio.com|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com